Myocardial Solutions, Inc. (MSI), who has pioneered the quantification of segmental cardiac strain testing to transform how physicians manage and monitor patient heart health, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued unique codes for MSI’s...
Myocardial Solutions, Inc. (MSI) was recognized in an article published by the CEO Views describing their selection for the “Most Innovative Companies to Watch in 2020” yearly list. The list highlights companies driving innovative technology solutions to challenge and transform the current ...
MyoStrain® was featured in the European Society of Cardiology’s (ESC) cardio-oncology webinar series to examine the role of MyoStrain in helping cardio-oncologists manage cardiac health for patients undergoing cancer therapy. As part of an educational grant sponsored by Myocardial Solutions...
Six new abstracts & posters showcasing MyoStrain were published as part of the American College of Cardiology’s (ACC) 69th Annual Scientific Session & Expo. The conference, which was scheduled to take place in Chicago, Illinois from March 28-30, was shifted to a virtual experience due to the...
Myocardial Solutions (MSI) enabled 16 new abstracts and five podium presentations showcasing the latest in MyoStrain insights to the Society for Cardiovascular Magnetic Resonance’s (SCMR) 23rd Annual Scientific...
